CPT — Copyright/Patent/Trademark
Intellectual Property Protections
Lobbyists: FRANCISCO CARRILLO
Government entities lobbied: HOUSE OF REPRESENTATIVES
1st Quarter - Report · 2026
- Filing UUID
2cc79e15-9bc4-4964-8548-7e08d69a08b5- Type
Q1— 1st Quarter - Report- Period
- first_quarter
- Year
- 2026
- Posted
- 2026-04-18 00:38:17
- Income (reported)
- —
- Expenses (reported)
- $4,420,000
- Expenses method
- A
- Filing document
- Open on lda.senate.gov
Registrant (lobbying firm)
Biopharmaceuticals
- Contact
- JENNIE SKELTON
- Phone
- +1 415-903-2800
- Address
- zip:20004, city:WASHINGTON, state:DC, street:1275 Pennsylvania Avenue, NW Suite 501
Client
- State
- DC
- Country
- US
- Government-entity client
- false
- Effective date
- 2018-02-15
Issues lobbied + lobbyists
HCR — Health Issues
Vaccine Coverage Pediatric Immunization Schedule Vaccine Injury Compensation Program Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients H.R. 7837 - Most Favored Patient Act of 2026 Lyme Disease Issues 340B Issues Counterfeit Drugs Inflation Reduction Act (IRA) Prescription Drug User Fee Act (PDUFA) Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage H.R. 5509 - Safe Step Act S. 2903 - Safe Step Act S. 3510 - Biosimilar Inspection Modernization Act of 2025
Lobbyists: FRANCISCO CARRILLO; EMILY MUELLER; MATTHEW STROIA; ms JENNIFER SWENSON WALTON; mrs ANGELA BOOTHE WILES
Government entities lobbied: Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE
MMM — Medicare/Medicaid
Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Prescription Drug User Fee Act (PDUFA) 340B Issues Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage PBM Reform Counterfeit Drugs P.L. 117-169 - Inflation Reduction Act (IRA) of 2022 Drug Pricing Medicare/Medicaid Issues
Lobbyists: EMILY MUELLER; MATTHEW STROIA; ms JENNIFER SWENSON WALTON; mrs ANGELA BOOTHE WILES
Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
TRD — Trade (domestic/foreign)
International Supply Chain Market Access Most Favored Nation Policies Foreign Freeriding Issues Non-Tariff Trade Barriers Competiveness Issues Trade Issues
Lobbyists: STEPHEN CLAEYS; EMILY MUELLER; CATHERINE ROBINSON; MATTHEW STROIA; ms JENNIFER SWENSON WALTON; mrs ANGELA BOOTHE WILES
Government entities lobbied: Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)